85 related articles for article (PubMed ID: 6319791)
21. The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences.
Bernhard MI; Pace RC; Unger SW; Wanebo HJ
J Immunol; 1980 Feb; 124(2):964-8. PubMed ID: 7356722
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence polarization immunoassay of estradiol.
Aucouturier P; Preud'homme JL; Lubochinsky B
Diagn Immunol; 1983; 1(4):310-4. PubMed ID: 6437726
[TBL] [Abstract][Full Text] [Related]
23. Flow cytofluorimetry of fluorescein fluorescence polarization to assay lymphocyte activation.
Dimitropoulos K; Rolland JM; Nairn RC
Biochem Biophys Res Commun; 1986 May; 136(3):1021-9. PubMed ID: 2424436
[TBL] [Abstract][Full Text] [Related]
24. CD3-/HLA-DR+, CD3+/HLA-DR+ cell levels and PHA stimulation of lymphocytes obtained from women with recurrent spontaneous abortions and subjected to partner's lymphocyte immunization.
Wilczyński J; Sułowska Z; Malinowski A; Zeman K; Szpakowski M; Tchórzewski H; Podciechowski L
Arch Immunol Ther Exp (Warsz); 1997; 45(4):289-94. PubMed ID: 9523003
[TBL] [Abstract][Full Text] [Related]
25. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.
Sakamoto S; Maeda H; Yamasaki K; Aikawa S; Hinuma Y
Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1105-15. PubMed ID: 7200019
[No Abstract] [Full Text] [Related]
27. Comparison of lipid composition and 1,6-diphenyl-1,3,5-hexatriene fluorescence polarization measurements of hairy cells with monocytes and lymphocytes from normal subjects and patients with chronic lymphocytic leukemia.
Liebes LF; Pelle E; Zucker-Franklin D; Silber R
Cancer Res; 1981 Oct; 41(10):4050-6. PubMed ID: 7285012
[TBL] [Abstract][Full Text] [Related]
28. [Effects of therapy, serology, stage and activity of rheumatoid arthritis on lymphocyte stimulation in whole blood].
Fritze U; Fritze D; Bicker U; Ewald RW; Friedberg KD
Z Rheumatol; 1983; 42(3):101-3. PubMed ID: 6880408
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of polarizing luminescence in the study of changes in the cytoplasm of lymphocytes--SCM test].
Benes J
Sb Lek; 1984 Sep; 86(8-9):245-50. PubMed ID: 6209784
[No Abstract] [Full Text] [Related]
30. Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes.
Jiang X; Paskind M; Weltzien R; Epstein PM
Cell Biochem Biophys; 1998; 28(2-3):135-60. PubMed ID: 9515164
[TBL] [Abstract][Full Text] [Related]
31. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
Blomgren H; Strender LE; Edsmyr F
Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
[TBL] [Abstract][Full Text] [Related]
32. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
[TBL] [Abstract][Full Text] [Related]
33. Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite.
Grinnell S; Yoshida K; Jasin HE
Arthritis Rheum; 2005 Jan; 52(1):80-3. PubMed ID: 15641043
[TBL] [Abstract][Full Text] [Related]
34. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
35. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
Hashimoto Y; Yamanaka T; Takaku F
Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
[TBL] [Abstract][Full Text] [Related]
36. Analysis of early lymphocyte activation events by fluorescence polarization flow cytometry.
Dimitropoulos K; Rolland JM; Nairn RC
Immunol Cell Biol; 1988 Aug; 66 ( Pt 4)():253-60. PubMed ID: 3155329
[TBL] [Abstract][Full Text] [Related]
37. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.
Dabrowski MP; Stankiewicz W; Płusa T; Chciałowski A; Szmigielski S
Mediators Inflamm; 2001 Jun; 10(3):101-7. PubMed ID: 11545246
[TBL] [Abstract][Full Text] [Related]
38. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
Braun DP; Harris JE
J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
[TBL] [Abstract][Full Text] [Related]
39. The study of a lymphokine, polymorphonuclear leukocyte chemotactic factor from lymphocytes in rheumatoid arthritis.
Pazdur J; Winney C; Baum J
J Clin Lab Immunol; 1982 Apr; 7(3):179-85. PubMed ID: 7047743
[TBL] [Abstract][Full Text] [Related]
40. [The effect of activating agents on the membrane potential of lymphocytes in hypertension patients].
Malaia LT; Koval' SN; Brovkovich VM; Kurilo NB
Biull Eksp Biol Med; 1993 Feb; 115(2):151-2. PubMed ID: 8043790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
